Development of Transdiagnostic Single-session Treatment

Development and Clinical Trial of a Transdiagnostic Single-session Treatment for Primary Care Patients

The goal of this clinical trial is to test a single session treatment program in primary care patients with anxiety and/or depression and/or stress-related issues. The main questions it aims to answer is:

• Will the transdiagnostic treatment program decrease symptoms of depression/anxiety/stress?
• Will the transdiagnostic treatment program decrease transdiagnostic risk factors?
• Will the transdiagnostic treatment program decrease the measured risk factors equally?
• Will the transdiagnostic treatment program impact patients with anxiety, depression or stress disorders equally?
• Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on transdiagnostic risk factors?
• Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on anxiety, depression, or stress-symptoms?
• Have the participants been able to generalize the skills taught in the program(qualitative)?
• Within group that were treated with single-session treatment and recieved additional care before follow-up, was there a difference in outcome?

The study investigates the effect of a single-session, 4 hour, transdiagnostic treatment for primary care patientst with depression, anxiety or stress.

The treatment includes, interoceptive exposure, behavioral activation, mindfulness, defusion and psycho-education about emotions.

The study is conducted in a clinical setting in northern sweden and follows up results at 3 weeks and 6 months post treatment.

Inclusion Criteria:

• Meet the criteria for anxiety, mood disorder, or stress diagnosis
• Symptoms are mild to moderate in severity

Exclusion Criteria:

• Already in ongoing psychotherapy
• Within a month commenced pharmaceutical treatment that will likely impact mood or psychological functioning and is not deemed to be on a stable dose
• Has a comorbid personality disorder
• Has a risk of suicide deemed other than low
• Has other severe psychological disorders outside the scope of primary care
• Is in a severely stressful social situation deemed incompatible with psychotherapy